GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 789 filers reported holding GLAXOSMITHKLINE PLC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $50,000 | -5.7% | 1,315 | +0.2% | 0.03% | -8.6% |
| Q1 2019 | $53,000 | +278.6% | 1,313 | +195.1% | 0.04% | +250.0% |
| Q4 2018 | $14,000 | -54.8% | 445 | -46.1% | 0.01% | -44.4% |
| Q3 2018 | $31,000 | +121.4% | 825 | +106.8% | 0.02% | +100.0% |
| Q2 2018 | $14,000 | +55.6% | 399 | +30.4% | 0.01% | +50.0% |
| Q1 2018 | $9,000 | -57.1% | 306 | -54.7% | 0.01% | -62.5% |
| Q4 2017 | $21,000 | – | 675 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |